PCR's 5 year investment journey
Article Information
Date: July 29, 2026

Share this

Prostate Cancer Research's Lessons from investing report highlights the charities journey to develop and deliver a mission-led investment model to accelerate innovation in prostate cancer. It outlines why the investment programme was created, how it operates, the impact it has achieved, key lessons learned and the challenges encountered.

This report also explores how PCR's model has evolved beyond investment through initiatives such as the TAR Network, PCR's data platform 'Prostate Progress' and cost benefit analysis model.  The report also set's out PCR's future ambitions to expand collaboration, our investment portfolio and support to accelerate the translation of research into patient benefit.